What Does Wall Street Think About Corcept Therapeutics (CORT)?

finance.yahoo.com/news/does-wall-street-think-corcept-143630116.html

Corcept Therapeutics Incorporated (NASDAQ:CORT) is one of the best stocks to buy with over 50% upside potential. Canaccord Genuity analyst Edward Nash maintained a Buy rating on Corcept Therapeutics Incorporated (NASDAQ:CORT) on October 21, setting a $140 price target.
Similarly, H.C.…

This story appeared on finance.yahoo.com, 2025-11-04 14:36:30.
The Entire Business World on a Single Page. Free to Use →